The market is filled with gapping stocks in Thursday's session. The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.
Bristol Myers Squibb Stock Earns 83 RS Rating On Thursday, Bristol Myers Squibb stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.
Wondering what's happening in today's pre-market session? Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Stock Market Today: Nvidia Drags Down Nasdaq Futures—Dollar General, Dell, Best Buy In Focus U.S. stock futures were swinging on Thursday following Wednesday's advances. Futures of major benchmark indices were largely mixed.
Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat Phibro shares soared nearly 18% after strong Q4 results beat estimates, driven by growth from the Zoetis MFA acquisition and solid full-year performance.
Phibro's Feed Play Pays Off: JPMorgan Upgrades On Zoetis Deal Boost Phibro Animal Health gains JPMorgan upgrade as analyst forecasts continued growth across key livestock products and long-term fundamentals.
Novartis Earns Near-Best Overall Rating As Profit Growth Climbs Novartis ranks No. 1 among in the 33-stock Medical-Ethical Drugs industry group. Novartis got a Composite Rating upgrade to 96 on Wednesday.
Novartis Earnings Surprised The Street; Still Going Strong Despite Market Correction Highly ranked Novartis is forming the right side of a long cup base with a buy point of 120.92. And it's literally running higher.
Bristol Myers Squibb Stock Gets Relative Strength Rating Upgrade On Friday, Bristol Myers Squibb stock earned an upgrade to its Relative Strength (RS) Rating, from 62 to 79.
